| Ietsugu, Hisashi (Sysmex 200602 CEO) |
Chief Executive Officer (CEO) |
Sysmex (Group) |
Japan |
| Ikeura, Yoshinori (Axcelead 201810 CEO) |
Chief Executive Officer (CEO) |
Axcelead Drug Discovery Partners Inc. (JP) |
Japan |
| Illek, Elmar (Bruker 201407 SVP Bruker Daltonics Commercial Operations before Thermo Fisher) |
Chief Commercial Officer (CCO) |
Bruker (Group) |
Germany |
| Illich, Damir J. (Wille 202210) |
Investment Manager |
Wille Finance AG |
Switzerland |
| Imbert, Tristan (Cimeio Therapeutics 202112 CFO before Novartis Gene Therapies + BCG + Aventis) |
Chief Financial Officer (CFO) |
Cimeio Therapeutics AG |
Switzerland |
| Imhof, Axel (LMU München 201504 Professor) |
Professor |
LMU Munich (Ludwig-Maximilians-Universität München, University of Munich) |
Germany |
| Imhof, René (Roche 200512) |
n. a. |
Roche (Group) |
Switzerland |
| Imhoff, Johannes F. (Leibniz-Gemeinschaft 201106 Professor + Head KiWiZ at IFM-GEOMAR) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| In-Albon, Beat (Lonza 201206– COO Life Science Ingredients sector before SGS 2006–2012 before Lonza) |
Chief Operating Officer (COO) |
Lonza (Group) |
Switzerland |
| Inabe, Kazu (Molcure 202410) |
n. a. |
Molcure Inc. (JP) |
Japan |
| Incerti, Carlo (Forbion 201901– Operating Partner before Sanofi Genzyme + Genzyme + Biofil Srl) |
Partner (venture partner) |
Forbion (Group) |
Netherlands |
| Ingendoh, Arnd (Syft Technologies 202101– VP Sales Europe before Bruker VP Life Sciences MS Sales EMEA + Thermo Fisher) |
Sales Manager / Marketing Manager |
Syft Technologies (Group) |
Germany |
| Ingram, Douglas S. (Doug) (Sarepta Therapeutics 201902 CEO) |
Chief Executive Officer (CEO) |
Sarepta Therapeutics Inc. (NASDAQ: SRPT) |
United States (USA) |
| Ingram, Piers (Hummingbird Bioscience 202105 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Hummingbird Bioscience (SG) |
Singapore |
| Ingvarsson, Staffan (Stockholm (govt) 202306 CEO of Stockholm Business Region) |
Chief Executive Officer (CEO) |
Stockholm (govt city) |
Sweden |
| Ingwers, Matthias (Calibre Scientific 202303 President of Operations Continental Europe) |
President/Director/Head Business Group/Unit/Division |
Calibre Scientific (Group) |
Germany |
| Ioannidou, Sofia (Andera Partners 202110 Partner before CHF Rothschild Investment Director at EdRIP) |
Investment Manager |
Andera Partners (FR) |
France |
| Iorio, Jonathan (Eisbach Bio 202405) |
Public Relations Manager / Investor Relations Manager |
Eisbach Bio GmbH |
Germany |
| Irsfeld, Marcus (iOmx Therapeutics 201910– CFO before ProCorde GmbH + Averitas Pharma Inc) |
Chief Financial Officer (CFO) |
iOmx Therapeutics AG |
Germany |
| Irvine, Alistair (Kuros 201508 CBO) |
Chief Business Officer (CBO) |
Kuros (Group) |
Switzerland |
| Ischia, Walter (Innerspace 202111 Managing Director) |
Managing Director |
Innerspace GmbH |
Austria |
| Iseli, Bernhard (Tecan –200803) |
n. a. |
Tecan (Group) |
Switzerland |
| Ishida, Noriaki (Daiichi Sankyo 201512 VP Corp Communications Dept) |
Public Relations Manager / Investor Relations Manager |
Daiichi Sankyo (Group) |
Japan |
| Ishnazarova, Nadiya (Merck (DE) 202303 at M Ventures) |
n. a. |
Merck (DE) (Group) |
Netherlands |
| Islam, Khalid (Gentium 200912– CEO before Arpida 199907–200805 CEO) |
Chief Executive Officer (CEO) |
Jazz Pharmaceuticals (Group) |
Italy |
| Itescu, Silviu (Mesoblast 201109 CEO) |
Chief Executive Officer (CEO) |
Mesoblast Ltd. (ASX: MSB, Nasdaq: MESO) |
Australia |
| Itin, Alexander (JSC Valenta Pharmaceuticals 201309 CEO) |
Chief Executive Officer (CEO) |
JSC Valenta Pharmaceuticals |
Russian Federation |
| Itin, Christian (Autolus 201603– CEO before Cytos 201211–201601 + Micromet 1999–2012 CEO + Co-founder + Zyomyx Inc) |
Chief Executive Officer (CEO) |
Autolus Therapeutics plc (Nasdaq: AUTL) |
United Kingdom (GB) |
| Itschert, Frank (BSSN Software GmbH 201908 Managing Director) |
Managing Director |
Merck (DE) (Group) |
Germany |
| Ittig, Simon Josef (T3 Pharmaceuticals 201909 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Boehringer Ingelheim (Group) |
Switzerland |
| Iva, Maryline (BeiGene 202205 Media Relations) |
Public Relations Manager / Investor Relations Manager |
BeiGene (Group) |
Switzerland |
| Ivanov, Igor (OncoLead 201012 Managing Director) |
Managing Director |
OncoLead (Group) |
Germany |
| Ivarrson, Mattias (Inositec 201610 CEO) |
Chief Executive Officer (CEO) |
Vifor Pharma (Group) |
Switzerland |
| Ivarsson, Carl-Johan (Qlucore AB 201209 CEO + Co-founder) |
Chief Executive Officer (CEO) |
Qlucore (Group) |
Sweden |
| Iversen, Morten E. (Sandwater 202310 Partner) |
Partner (venture partner) |
Sandwater (NO) |
Norway |
| Ivkin, Michael (HTS Biochemie-Innovationen 202411 Managing Director) |
Managing Director |
HTS Biochemie-Innovationen GmbH |
Germany |
| Iyer, Mohan (Second Genome 201503 CBO) |
Chief Business Officer (CBO) |
Second Genome Inc. |
United States (USA) |
| Izzo, Marina (EBAMed 202101– CEO before Cardionovum + Symetis + Medtronic Europe + St Jude Medical) |
Chief Executive Officer (CEO) |
EBAMed S.A. |
Switzerland |
| Jabbour, Jerome D. (Jerry) (Matinas BioPharma 202204 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Matinas BioPharma (Group) |
United States (USA) |
| Jablonka, Bernd (Sanofi 201710 Strategy + Business Development, Public Private Partnership Sanofi Germany) |
Business Development Manager / Strategy Manager |
Sanofi (Group) [since May 2011] |
Germany |
| Jacanin, Laura (Genezen 202201– Senior Director Business Development before Cytovance + Lonza + Wuxi) |
Business Development Manager / Strategy Manager |
Genezen Inc. (Genezen Laboratories) |
United States (USA) |
| Jackson, Oliver (Peel Hunt 201707) |
n. a. |
Peel Hunt LLP |
United Kingdom (GB) |
| Jacob, Tobias (High-Tech Gründerfonds 202305 Senior Marketing + Communications Manager) |
Public Relations Manager / Investor Relations Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Jacobi, Philipp (Quadriga Capital 201811 Managing Partner) |
Managing Partner (investment firm) |
Quadriga Capital Eigenkapitalberatung GmbH |
|
| Jacobs, Bruce (Kymera Therapeutics 201907– CFO before Westfield Capital Management + Alex Brown & Sons/Deutsche Bank) |
Chief Financial Officer (CFO) |
Kymera Therapeutics Inc. (Nasdaq: KYMR) |
United States (USA) |
| Jacobs, Elena M. (Eppendorf 201409) |
n. a. |
Eppendorf (Group) |
Germany |
| Jacobs, Peter (Thermo Fisher 202411 EMEA Clinical Business Development) |
n. a. |
Thermo Fisher (Group) |
United States (USA) |
| Jacotot, Frederic (Valneva 201704– General Counsel + Board Member joined 2013 before Abbott) |
General Counsel / Chief Legal Officer (CLO) |
Valneva (Group) |
France |
| Jaeger, Axel (Eppendorf 202006– CFO before Wash Tec AG + Carl Zeiss Group) |
Chief Financial Officer (CFO) |
Eppendorf (Group) |
Germany |
| Jaehnig,Tina (Sachsen (govt) 202210 Saxony Trade + Invest Life Sciences) |
Trade Promotion Manager / Regional Business Development Manager |
Saxony (govt region) |
Germany |
| Jaehnke, Torsten (Bruker 201909 Director of BioAFM) |
Product Manager (personnel) |
Bruker (Group) |
Germany |
| Jaenichen, Hans-Rainer (Vossius & Partner 200809 Munich) |
n. a. |
Vossius & Partner patent attorneys |
Germany |
| Jaffré, Marc (Merck (DE) 202204 Managing Director of Life Science Business Sector in China) |
Managing Director |
Merck (DE) (Group) |
Germany |
| Jaffrey, Samie (Weill Cornell Medicine 201810 Prof of Pharmacology + Co-Founder of Gotham Therapeutics) |
Professor |
Cornell University |
United States (USA) |
| Jafry, Syed (Thermo Fisher 201505 SVP + President Asia-Pacific + Emerging Markets) |
President/Director/Head Business Group/Unit/Division |
Thermo Fisher (Group) |
United States (USA) |
| Jager, Martin (BASF 201202 Global Head Animal Nutrition Business) |
President/Director/Head Business Group/Unit/Division |
BASF (Group) |
Germany |
| Jager, Ronald (PGS.Holland 201712 Managing Director) |
Managing Director |
PGS.Holland B.V. |
Netherlands |
| Jagiella, Manfred (Endress+Hauser 201711 Group Board Member responsible for analytical business) |
Board member, executive |
Endress+Hauser (Group) |
|
| Jagielski, Mike (KCR CRO 201309– CEO joined 201201 before Merck & Co) |
Chief Executive Officer (CEO) |
KCR CRO (Group) |
Poland |
| Jahn, Melanie (Analytik Jena 201708 Product Manager) |
product management |
Endress+Hauser (Group) |
Germany |
| Jahn, Stefan (Thuringia (govt) 202306 Senior Investment Manager at bm-t) |
Investment Manager |
Thuringia (govt region) |
Germany |
| Jain, Kewal |
n. a. |
Jain PharmaBiotech |
|
| Jakob, Uwe (Suppremol 200808 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Baxter (Group) |
Germany |
| Jakobs, Roy (Philips 202402 CEO) |
Chief Executive Officer (CEO) |
Philips (Group) |
Netherlands |
| Jakobsen, Bent (Accession Therapeutics 202109– CEO before Adaptimmune + Immunocore + Avidex + IMM Oxford) |
Chief Executive Officer (CEO) |
Accession Therapeutics (Group) |
United Kingdom (GB) |
| Jakobsohn, Meir (Medison Pharma 201401 CEO + Founder) |
Chief Executive Officer (CEO) |
Medison Pharma (Group) |
Israel |
| Jaksch, Stefan (Ionicon 201003 Sales Engineer) |
Sales Manager / Marketing Manager |
Ionicon (Group) |
Austria |
| Jallal, Bahija (Immunocore 201901– CEO before AstraZeneca President MedImmune joined MedImmune 2006) |
Chief Executive Officer (CEO) |
Immunocore (Group) |
United Kingdom (GB) |
| Jamal, Waheed (Boehringer Ingelheim 201912 Corp VP + Head of CardioMetabolic Medicine) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
| James, Alison (Coulter Partners 201712 Director PR + Marketing) |
Public Relations Manager / Investor Relations Manager |
Coulter Partners (The Coulter Partnership Ltd.) |
United Kingdom (GB) |
| James, David (Danaher 201404 SVP Diagnostics at Invetech) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
United States (USA) |
| James, Desmond D. (Trophic Communications 202110) |
Public Relations Manager / Investor Relations Manager |
Trophic Communications GmbH |
Germany |
| Jaminet, Paul (Angiex 201708 CEO) |
Chief Executive Officer (CEO) |
Angiex Inc. |
United States (USA) |
| Jandrinitsch, Markus (Austria (govt) 202111 Investment Manager of aws Gründerfonds) |
Managing Director |
Austria (govt) |
Austria |
| Janezic, Marco J. (Eternygen 201407 Managing Director + 202207 Managing Director Life Science Factory) |
Managing Partner |
Eternygen (Group) |
Germany |
| Jankowsky, Rüdiger (Infarco 201510– Managing Director at Cinfa Biotech GmbH) |
Managing Director |
Infarco (Group) |
Germany |
| Janositz, Paul |
journalism |
|
|
| Jansen, Carin (LifeTecAachen-Jülich 201307 Managing Director) |
Cluster Manager |
LifeTecAachen Jülich e. V. |
Germany |
| Jansen, Katharina (Life Science Valley 202204– before Bayer) |
Cluster Manager |
Life Science Valley (Sartorius / Niedersachsen/ Univ Göttingen) (Group) |
Germany |
| Jansen, Kathrin U. (Pfizer 201501 SVP + CSO Vaccine Research + Early Development) |
President/Director/Head Business Group/Unit/Division |
Pfizer (Group) |
United States (USA) |
| Jansen, Sven (Noventi 202202 Executive Board Member) |
Board member, executive |
Noventi (Group) |
Germany |
| Janssen, Egbert (Celsius79.com AG 201212 Vorstand) |
Board member, executive |
Celsius37.com AG |
Germany |
| Janssen, Gunnar (AMP Biosimilars 201505– CFO before AMP Supervisory Board Member + German Private Equity GmbH) |
Chief Financial Officer (CFO) |
AMP Biosimilars AG |
Germany |
| Janssen, Uwe (Miltenyi Biotec 201008 Business Development) |
Business Development Manager / Strategy Manager |
Miltenyi Biotec (Group) |
Germany |
| Janssens, Rogier (Merck (DE) 201901 Managing Director + General Manager Biopharma Business in China) |
Managing Director |
Merck (DE) (Group) |
Germany |
| Jantzen, Eckard (GALAB Laboratories GmbH 201203 Managing Director) |
Managing Director |
GALAB Technologies GmbH |
Germany |
| Janus, Friedemann (Bayer 202306 acting Head of Business Development + Licewnsing/Open Innvation for Pharma Div) |
Business Development Manager / Strategy Manager |
Bayer (Group) |
Germany |
| Jaquemar, Markus (BD 2013001– Business Director Diagnostics Central Europe before Anagnostics + Agilent + Beckman) |
Regional manager |
Becton, Dickinson (Group) |
Germany |
| Jardine, Ian (Thermo Fisher 200803 VP Global Research + Develop) |
Research & Development Manager |
Thermo Fisher (Group) |
United States (USA) |
| Jaskolski, Janik (Semalytix 201505– Managing Director + Co-Founder) |
Managing Director |
Semalytix GmbH |
Germany |
| Jazdowski, Oscar (SVB 202101 General Manager Silicon Valley Bank German Branch) |
General Manager (management) |
SVB (Silicon Valley Bank) (Group) |
Germany |
| Jean-Mairet, Joël (Ysios Capital 201206) |
n. a. |
Ysios Capital (Group) |
Spain (España) |
| Jeddeloh, Jeffrey A. (DNA Script 201811– VP BusDev + Commercial Strategy before Roche + Orion Genomics) |
Business Development Manager / Strategy Manager |
DNA Script (Group) |
United States (USA) |
| Jeffreys, Hayden (Lumora 2013– Commercial Director) |
Chief Commercial Officer (CCO) |
Erba Diagnostics Mannheim (Group) |
United Kingdom (GB) |
| Jegge, Gabriele (Medigene 201612 Investor + Public Relations) |
Public Relations Manager / Investor Relations Manager |
Medigene (Group) |
Germany |
| Jeggle, Helmut (STRÜNGMANN Group + before Hexal + scine 2009 Apceth Managing Director CFO) |
Investment Manager |
STRÜNGMANN Group (family Strüngmann) |
Germany |
| Jehle, Armin (Agilent 202407 VP Agilent CrossLab Services Division) |
President/Director/Head Business Group/Unit/Division |
Agilent (Group) |
United States (USA) |
| Jehle, Heinrich (3a-diagnostics 201910– Managing Director) |
Managing Director |
XPhyto Therapeutics (Group) |
Germany |
| Jehle, Regina (Abivax 201912– Director of Communications before BioNTech 2014– 2019) |
Public Relations Manager / Investor Relations Manager |
Abivax (Group) |
France |
| Jeker, Rene (Bruker Corp 201004 Managing Director Bruker BioSpin AG Switzerland) |
Managing Director |
Bruker (Group) |
Switzerland |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 36 37 38 ... 93 94 95 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
